位置:首页 > 蛋白库 > VGR2B_PSEAE
VGR2B_PSEAE
ID   VGR2B_PSEAE             Reviewed;        1019 AA.
AC   Q9I6M7;
DT   26-FEB-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   03-AUG-2022, entry version 100.
DE   RecName: Full=Type VI secretion system spike protein VgrG2b {ECO:0000303|PubMed:31577948};
DE   AltName: Full=Metallopeptidase effector VgrG2b {ECO:0000303|PubMed:31577948};
DE            EC=3.4.24.- {ECO:0000269|PubMed:31577948};
GN   Name=vgrG2b; OrderedLocusNames=PA0262;
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   HOST GCP1 AND GCP4.
RX   PubMed=26037124; DOI=10.1128/mbio.00712-15;
RA   Sana T.G., Baumann C., Merdes A., Soscia C., Rattei T., Hachani A.,
RA   Jones C., Bennett K.L., Filloux A., Superti-Furga G., Voulhoux R.,
RA   Bleves S.;
RT   "Internalization of Pseudomonas aeruginosa Strain PAO1 into Epithelial
RT   Cells Is Promoted by Interaction of a T6SS Effector with the Microtubule
RT   Network.";
RL   MBio 6:E00712-E00712(2015).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, MUTAGENESIS OF HIS-935; GLU-936 AND
RP   HIS-939, ACTIVE SITE, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=31577948; DOI=10.1016/j.celrep.2019.08.094;
RA   Wood T.E., Howard S.A., Foerster A., Nolan L.M., Manoli E., Bullen N.P.,
RA   Yau H.C.L., Hachani A., Hayward R.D., Whitney J.C., Vollmer W.,
RA   Freemont P.S., Filloux A.;
RT   "The Pseudomonas aeruginosa T6SS Delivers a Periplasmic Toxin that Disrupts
RT   Bacterial Cell Morphology.";
RL   Cell Rep. 29:187-201(2019).
RN   [4]
RP   FUNCTION, INTERACTION WITH TLA3, AND DISRUPTION PHENOTYPE.
RX   PubMed=31231326; DOI=10.3389/fmicb.2019.01218;
RA   Berni B., Soscia C., Djermoun S., Ize B., Bleves S.;
RT   "A Type VI Secretion System Trans-Kingdom Effector Is Required for the
RT   Delivery of a Novel Antibacterial Toxin in Pseudomonas aeruginosa.";
RL   Front. Microbiol. 10:1218-1218(2019).
RN   [5] {ECO:0007744|PDB:6H56}
RP   X-RAY CRYSTALLOGRAPHY (3.20 ANGSTROMS) OF 770-1019.
RA   Wood T.E., Forster A., Manoli E., Howard S., Hachani A., Hayward A.D.,
RA   Freemont P.S., Filloux A.;
RT   "Effector domain of Pseudomonas aeruginosa VgrG2b.";
RL   Submitted (JUL-2018) to the PDB data bank.
CC   -!- FUNCTION: Part of the H2 type VI secretion system (H2-T6SS) specialized
CC       secretion system, which delivers several virulence factors in both
CC       prokaryotic and eukaryotic cells during infection (PubMed:26037124,
CC       PubMed:31577948, PubMed:31231326). Forms the spike at the tip of the
CC       elongating tube probably formed by haemolysin co-regulated protein
CC       2b/Hcp2b (Probable). Allows the delivery of the Tle3 antibacterial
CC       toxin to target cells where it exerts its toxicity (PubMed:31231326).
CC       Additionally, acts directly as an effector and promotes internalization
CC       by interacting with the host gamma-tubulin ring complex
CC       (PubMed:26037124). Elicits toxicity also in the bacterial periplasm and
CC       disrupts bacterial cell morphology. Toxicity is counteracted by a
CC       cognate immunity protein (PubMed:31577948).
CC       {ECO:0000269|PubMed:26037124, ECO:0000269|PubMed:31231326,
CC       ECO:0000269|PubMed:31577948, ECO:0000305|PubMed:31231326}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:31577948};
CC   -!- SUBUNIT: Interacts with Tla3; this interaction promotes Tle3 loading
CC       onto VgrG2b. Interacts with host gamma-tubulin ring complex components
CC       GCP1 and GCP4. {ECO:0000269|PubMed:31231326}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:26037124,
CC       ECO:0000269|PubMed:31577948}. Note=Secreted by the H2 type VI (H2-T6SS)
CC       secretion system involving VgrG2a into host cells upon infection.
CC       {ECO:0000269|PubMed:26037124}.
CC   -!- DOMAIN: The C-terminal region is part of a wide family of
CC       metallopeptidase effectors. {ECO:0000269|PubMed:31577948}.
CC   -!- DISRUPTION PHENOTYPE: Deletion leads to a 75% loss of internalization
CC       of P.aeruginosa into host cell. {ECO:0000269|PubMed:26037124}.
CC   -!- SIMILARITY: Belongs to the VgrG protein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG03651.1; -; Genomic_DNA.
DR   PIR; A83613; A83613.
DR   RefSeq; NP_248953.1; NC_002516.2.
DR   RefSeq; WP_003147109.1; NZ_CP053028.1.
DR   PDB; 6H56; X-ray; 3.20 A; A/B=770-1019.
DR   PDBsum; 6H56; -.
DR   AlphaFoldDB; Q9I6M7; -.
DR   SMR; Q9I6M7; -.
DR   STRING; 287.DR97_3224; -.
DR   PaxDb; Q9I6M7; -.
DR   EnsemblBacteria; AAG03651; AAG03651; PA0262.
DR   GeneID; 881981; -.
DR   KEGG; pae:PA0262; -.
DR   PATRIC; fig|208964.12.peg.273; -.
DR   PseudoCAP; PA0262; -.
DR   HOGENOM; CLU_004121_1_4_6; -.
DR   OMA; NADAQHN; -.
DR   PhylomeDB; Q9I6M7; -.
DR   BioCyc; PAER208964:G1FZ6-264-MON; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0033104; C:type VI protein secretion system complex; IGC:PseudoCAP.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0033103; P:protein secretion by the type VI secretion system; IGC:PseudoCAP.
DR   Gene3D; 2.40.50.230; -; 1.
DR   InterPro; IPR006531; Gp5/Vgr_OB.
DR   InterPro; IPR028244; T6SS_Rhs_Vgr_dom.
DR   InterPro; IPR017847; T6SS_RhsGE_Vgr_subset.
DR   InterPro; IPR006533; T6SS_Vgr_RhsGE.
DR   InterPro; IPR037026; Vgr_OB-fold_dom_sf.
DR   InterPro; IPR018769; VgrG2_C_DUF2345.
DR   Pfam; PF10106; DUF2345; 1.
DR   Pfam; PF04717; Phage_base_V; 1.
DR   Pfam; PF13296; T6SS_Vgr; 1.
DR   TIGRFAMs; TIGR01646; vgr_GE; 1.
DR   TIGRFAMs; TIGR03361; VI_Rhs_Vgr; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Metal-binding; Reference proteome; Secreted; Zinc.
FT   CHAIN           1..1019
FT                   /note="Type VI secretion system spike protein VgrG2b"
FT                   /id="PRO_0000448915"
FT   REGION          268..291
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        268..289
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        936
FT                   /evidence="ECO:0000269|PubMed:31577948,
FT                   ECO:0007744|PDB:6H56"
FT   BINDING         935
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:31577948,
FT                   ECO:0007744|PDB:6H56"
FT   BINDING         939
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:31577948,
FT                   ECO:0007744|PDB:6H56"
FT   BINDING         983
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:31577948,
FT                   ECO:0007744|PDB:6H56"
FT   MUTAGEN         935
FT                   /note="H->A: Abolishes bacterial periplasmic toxicity."
FT                   /evidence="ECO:0000269|PubMed:31577948"
FT   MUTAGEN         936
FT                   /note="E->A: Abolishes bacterial periplasmic toxicity."
FT                   /evidence="ECO:0000269|PubMed:31577948"
FT   MUTAGEN         939
FT                   /note="H->A: Abolishes bacterial periplasmic toxicity."
FT                   /evidence="ECO:0000269|PubMed:31577948"
FT   HELIX           834..854
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           868..878
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   TURN            884..886
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   STRAND          888..892
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   STRAND          906..912
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           914..916
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           922..924
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           927..944
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           949..962
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           977..979
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           982..998
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   HELIX           1000..1008
FT                   /evidence="ECO:0007829|PDB:6H56"
FT   TURN            1009..1011
FT                   /evidence="ECO:0007829|PDB:6H56"
SQ   SEQUENCE   1019 AA;  112964 MW;  51303C0019689C30 CRC64;
     MRQRDLKFTF VVGEGKLAFD VVEFELEEAL CEPFRLNLKL ASDKNAIDFK QVLDQPGTFT
     LWQDGRPARY VHGIVSHFTQ GSSGFRRTRY ELLLEPQLAR LELCCNWRIF QEKSVPEILQ
     ALLKEHRVLD YEQRIYHEHL PREYCVQAGD SDHYLHDRLA FEEGLVYYFR FDEHRHTLVC
     SDRLYVQERI AGGPVLFSAQ PEGDNPQPVL HSFRYSENVR TARQTQRDYS FKRPTYDQEH
     HLAGEALEHQ GSSYERYDYP GRYKRSGAGR PFTESRLRGH RRDARVASVS GDDPRLIPGH
     AFALEGHPRA DFNAWWRPVR VVHRGTQYAG QEEESADAPL GVSYDLRAEL VPEDVEWRPA
     PLPRPRIDGP QIATVVGPAG EEIHCDEWGR VKVQFPWDRE GRHDEFSTCW IRVAQNWAGA
     DWGHMAIPRI GQEVIVDYLD GDCDQPIVTG RTYRATNRPP YALPDHKILS TIKSKEYKGS
     RANELRIDDT TAQISAALMS DHGASALHLG YLTHPRPEGG KPRGEGFELR TDEHGAVRAA
     KGLLLSTEEQ LRAGAGHLDR GVVVQVLEAA LELARELGDY AGEHQGVGHD AAPQQTLQEA
     VRDLGHGAND ESGKSNGGKP AIALSGPAGI AAATPASLTL AAGEHVDSVA RQNQQVTAGQ
     KVVINAGSDI GLFAQGGELR QITHQGPMLL QAQKNDIRLE AKQSVEVSAS QQHVLVTAKE
     HITLMCGGAY LTLKGGNIEL GMPGNFVVKA AKHSHVGAAS LEAELPQFEV GETQRRFVLK
     QLDGQTAMPN VPYTITMANG EVIEGVTDAE GATQLLQKDA MNIAKVDMKH TKSPASAVAG
     IAAAVGAAVA VGKLLGGPDA EAGRALSEGE ISLAKGVFGD SIDYSTVRLR DEDYVPWQGK
     DYVMAPNGHI YFGEELRGVA DWSLESLQRQ GLFIHEMTHV WQHQHGVNVL LVGAYQQARQ
     FLLGDQYAYR LEPGKTLKDY NIEQQGDIVR DYFLEKNEFG EASANSRFAG VLKNFPTGY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024